OneOncology and Clearview Cancer Institute of Huntsville finalized a new partnership for the delivery of cancer care services throughout Alabama.
OneOcology has announced the finalization of a partnership with Huntsville’s Clearview Cancer Institute (CCI). This new collaboration will support the delivery of cancer-related services throughout Alabama communities. With this recent merge, the Alabama cancer care practice is now the 20th of its kind to join OneOncology.
CCI operates in 13 cancer care clinics throughout Alabama including Florence, Oxford, Decatur, Scottsboro, Cullman, Jasper, the communities of North Alabama, and Huntsville. At present, this organization constitutes the biggest community oncology practice in Alabama and one of the largest in the nation.
Marshal Schreeder, MD
Image credit: clearviewcancer.com
“As one of CCI’s founders and someone who has practiced in Huntsville since 1979, I’ve experienced how community oncology has changed and given our patients high-quality cancer care treatment options close to home,” said Marshall Schreeder, MD, in a statement. “In my 30-year career, I’ve never been as excited for our future as I am now due to our partnership with OneOncology. By affiliating with leading oncology practices and physicians across the country, we will continue to grow and expand access to care throughout North Alabama.”
“Partnering with OneOncology will accelerate our growth trajectory across Alabama,” commented John Waples, MD. “OneOncology’s backbone infrastructure, data analytics, and unparalleled expertise assisting growth-oriented practices will unlock opportunities for our physicians and other practices across Alabama to expand patient access to high-quality cancer care at costs far below hospitals, all while maintaining practice independence.”
Those affected by cancer can expect available services in the realm of oral pharmacy, laboratory, clinical research, infusion, and imaging with technology such as MRI, PET/CT scans, and ultrasound.
CCI vows to offer personalized health care that is close to home. As an organization that has been making an impact in Alabama for more than 30 years, their joint efforts with OneOncology will bolster the quality forms of care they already offer to patients in need.
“I have known and respected Drs. Schreeder and Waples and Gary Walton at CCI for over 20 years. Having such a successful practice join our partnership is both validating and gratifying,” Jeff Patton, MD, CEO, OneOncology, remarked. “We’re excited to help the practice grow and add cancer care services beneficial to their community. Our partnership will bring value to Alabama employers and payers as OneOncology continues to innovate clinically and deliver high-value cancer care.”
Reference
Hoffman E. OneOncology partners with Huntsville’s Clearview Cancer Institute. News release. January 11, 2024. Accessed January 15, 2024. https://www.oneoncology.com/blog/oneoncology-partners-with-huntsvilles-clearview-cancer-institute/
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen